CTLA-4 in complex with tremelimumab Fab

Order alaning scaning of CTLA-4 in complex with tremelimumab Fab

Tremelimumab, manufactured by AstraZeneca, is an immunotherapy treatment that helps the immune system recognize and attack cancer cells. Clinical trials are testing the drug on several different cancers including mesothelioma.Tremelimumab (formerly ticilimumabCP-675,206) is a fully human monoclonal antibody against CTLA-4. It is an immune checkpoint blocker.


You can now get a table of the values of the potential energy of electrostatic interaction between CTLA-4 and tremelimumab Fab1  just for 156 EURO

human monoclonal antibody against CTLA-4. It is an immune checkpoint blocker.
The table of values of potential energies in the formation CTLA-4 in complex with tremelimumab Fab1

You can now get a table of the values of the potential energy of electrostatic interaction between CTLA-4 and tremelimumab Fab1  just for 156 EURO

a table of the values of the potential energy of electrostatic interaction between   CTLA-4 and tremelimumab Fab1  just for 156 EURO
The table of values of potential energies in the formation CTLA-4 in complex with tremelimumab Fab2

You can order alanine scanning or mutagenesis (from 15 substitutions of amino acid residues) from 3500 Euro. A detailed study of the properties of the protein complex Fab1-Fab2- CTLA-4 from 7890 Euro

error

Enjoy this blog? Please spread the word :)

Follow by Email
Share